Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Caroline J Coats*, Ahmad Masri, Michael E Nassif, Roberto Barriales-Villa, Michael Arad, Nuno Cardim, Lubna Choudhury, Brian Claggett, Hans-Dirk Düngen, Pablo Garcia-Pavia, Albert A Hagège, James L Januzzi, Matthew M Y Lee, Gregory D Lewis, Chang-Sheng Ma, Martin S Maron, Zi Michael Miao, Michelle Michels, Iacopo Olivotto, Artur OreziakAnjali T Owens, John A Spertus, Scott D Solomon, Jacob Tfelt-Hansen, Marion van Sinttruije, Josef Veselka, Hugh Watkins, Daniel L Jacoby, Polina German, Stephen B Heitner, Stuart Kupfer, Justin D Lutz, Fady I Malik, Lisa Meng, Amy Wohltman, Theodore P Abraham, SEQUOIA‐HCM Investigators *
Dyk ned i forskningsemnerne om 'Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM'. Sammen danner de et unikt fingeraftryk.